mRNA in vitro Transcription and LNP for protein, Antibody and CAR Engineering

Join ProMab Biotechnologies on September 12th, 2024, for a webinar with Vita Golubovskaya, Ph.D., ProMab’s VP of Research, as she discusses advancements in mRNA-LNP technology, including bispecific antibodies and CAR technology. Discover how ProMab’s innovations can elevate your research.